These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25892508)

  • 1. Impact of cytokine in type 1 narcolepsy: Role of pandemic H1N1 vaccination ?
    Lecendreux M; Libri V; Jaussent I; Mottez E; Lopez R; Lavault S; Regnault A; Arnulf I; Dauvilliers Y
    J Autoimmun; 2015 Jun; 60():20-31. PubMed ID: 25892508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
    Lind A; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson AL; Bomfim IL; Fink K; Lernmark Å
    J Autoimmun; 2014 May; 50():99-106. PubMed ID: 24485154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.
    Dauvilliers Y; Arnulf I; Lecendreux M; Monaca Charley C; Franco P; Drouot X; d'Ortho MP; Launois S; Lignot S; Bourgin P; Nogues B; Rey M; Bayard S; Scholz S; Lavault S; Tubert-Bitter P; Saussier C; Pariente A;
    Brain; 2013 Aug; 136(Pt 8):2486-96. PubMed ID: 23884811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case-control study.
    Dauvilliers Y; Jaussent I; Lecendreux M; Scholz S; Bayard S; Cristol JP; Blain H; Dupuy AM
    Brain Behav Immun; 2014 Mar; 37():260-6. PubMed ID: 24394344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical screening for antibodies in recent onset type 1 narcolepsy and after H1N1 vaccination.
    van der Heide A; Hegeman-Kleinn IM; Peeters E; Lammers GJ; Fronczek R
    J Neuroimmunol; 2015 Jun; 283():58-62. PubMed ID: 26004157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.
    Ahmed SS; Volkmuth W; Duca J; Corti L; Pallaoro M; Pezzicoli A; Karle A; Rigat F; Rappuoli R; Narasimhan V; Julkunen I; Vuorela A; Vaarala O; Nohynek H; Pasini FL; Montomoli E; Trombetta C; Adams CM; Rothbard J; Steinman L
    Sci Transl Med; 2015 Jul; 7(294):294ra105. PubMed ID: 26136476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination.
    Partinen M; Kornum BR; Plazzi G; Jennum P; Julkunen I; Vaarala O
    Lancet Neurol; 2014 Jun; 13(6):600-13. PubMed ID: 24849861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.
    Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S
    J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk.
    Vaarala O; Vuorela A; Partinen M; Baumann M; Freitag TL; Meri S; Saavalainen P; Jauhiainen M; Soliymani R; Kirjavainen T; Olsen P; Saarenpää-Heikkilä O; Rouvinen J; Roivainen M; Nohynek H; Jokinen J; Julkunen I; Kilpi T
    PLoS One; 2014; 9(12):e114361. PubMed ID: 25501681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy.
    De la Herrán-Arita AK; Kornum BR; Mahlios J; Jiang W; Lin L; Hou T; Macaubas C; Einen M; Plazzi G; Crowe C; Newell EW; Davis MM; Mellins ED; Mignot E
    Sci Transl Med; 2013 Dec; 5(216):216ra176. PubMed ID: 24353159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases.
    Ambati A; Poiret T; Svahn BM; Valentini D; Khademi M; Kockum I; Lima I; Arnheim-Dahlström L; Lamb F; Fink K; Meng Q; Kumar A; Rane L; Olsson T; Maeurer M
    J Intern Med; 2015 Sep; 278(3):264-76. PubMed ID: 25683265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination.
    Thebault S; Waters P; Snape MD; Cottrell D; Darin N; Hallböök T; Huutoniemi A; Partinen M; Pollard AJ; Vincent A
    PLoS One; 2015; 10(6):e0129555. PubMed ID: 26090827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.
    Wijnans L; Lecomte C; de Vries C; Weibel D; Sammon C; Hviid A; Svanström H; Mølgaard-Nielsen D; Heijbel H; Dahlström LA; Hallgren J; Sparen P; Jennum P; Mosseveld M; Schuemie M; van der Maas N; Partinen M; Romio S; Trotta F; Santuccio C; Menna A; Plazzi G; Moghadam KK; Ferro S; Lammers GJ; Overeem S; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MC
    Vaccine; 2013 Feb; 31(8):1246-54. PubMed ID: 23246544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
    Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
    Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic.
    Magalhaes I; Eriksson M; Linde C; Muhammad R; Rane L; Ambati A; Axelsson-Robertson R; Khalaj B; Alvarez-Corrales N; Lapini G; Montomoli E; Linde A; Pedersen NL; Maeurer M
    BMC Infect Dis; 2014 Jun; 14():319. PubMed ID: 24916787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell reactivity to regulatory factor X4 in type 1 narcolepsy.
    Luo G; Yogeshwar S; Lin L; Mignot EJ
    Sci Rep; 2021 Apr; 11(1):7841. PubMed ID: 33837283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.
    Luo G; Ambati A; Lin L; Bonvalet M; Partinen M; Ji X; Maecker HT; Mignot EJ
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12323-E12332. PubMed ID: 30541895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narcolepsy and H1N1 vaccination: a link?
    Thebault S; Vincent A; Gringras P
    Curr Opin Pulm Med; 2013 Nov; 19(6):587-93. PubMed ID: 24048081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls.
    Lind A; Freyhult E; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Lima Bomfim I; Fink K; Fex M; Törn C; Elding Larsson H; Lernmark Å
    Viral Immunol; 2017 Oct; 30(8):590-600. PubMed ID: 28796576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.